Search

Your search keyword '"Demir, Münevver"' showing total 180 results

Search Constraints

Start Over You searched for: Author "Demir, Münevver" Remove constraint Author: "Demir, Münevver" Search Limiters Full Text Remove constraint Search Limiters: Full Text
180 results on '"Demir, Münevver"'

Search Results

1. Interleukin‐18 signaling promotes activation of hepatic stellate cells in mouse liver fibrosis

2. The fecal mycobiome in non-alcoholic fatty liver disease ☆

3. Colesevelam ameliorates non-alcoholic steatohepatitis and obesity in mice

4. Soluble urokinase plasminogen activator receptor levels predict survival in patients with portal hypertension undergoing TIPS

6. Combined analysis of gut microbiota, diet and PNPLA3 polymorphism in biopsy‐proven non‐alcoholic fatty liver disease

7. Intestinal Virome Signature Associated With Severity of Nonalcoholic Fatty Liver Disease

8. Treating hepatitis D with bulevirtide – Real-world experience from 114 patients

10. Efficacy of finerenone in patients with type 2 diabetes, chronic kidney disease and altered markers of liver steatosis and fibrosis: A FIDELITY subgroup analysis

11. Efficacy of finerenone in patients with type 2 diabetes, chronic kidney disease and altered markers of liver steatosis and fibrosis:A FIDELITY subgroup analysis

15. Liver fat as risk factor of hepatic and cardiometabolic diseases

16. The fecal mycobiome in non-alcoholic fatty liver disease.

17. Maternal exercise conveys protection against NAFLD in the offspring via hepatic metabolic programming

22. Cenicriviroc for the treatment of COVID-19: first interim results of a randomised, placebo-controlled, investigator-initiated, double-blind phase II trial

23. Validation of risk scores for allograft failure after liver transplantation in Germany: a retrospective cohort analysis

24. Validation of risk scores for allograft failure after liver transplantation in Germany: a retrospective cohort analysis

26. Kentleşme Sürecinin Türk Sineması’na Yansıması: Bitmeyen Yol Film Örneği

27. The fecal mycobiome in non-alcoholic fatty liver disease.

28. Perinatal Obesity Induces Hepatic Growth Restriction with Increased DNA Damage Response, Senescence, and Dysregulated Igf-1-Akt-Foxo1 Signaling in Male Offspring of Obese Mice

30. Complement activation induces excessive T cell cytotoxicity in severe COVID-19

33. Complement activation induces excessive T cell cytotoxicity in severe COVID-19

34. Kentleşme sürecinin Türk sinemasına yansıması

35. The APAC Score: A Novel and Highly Performant Serological Tool for Early Diagnosis of Hepatocellular Carcinoma in Patients with Liver Cirrhosis

37. Macrophage migration inhibitory factor predicts an unfavorable outcome after transarterial chemoembolization for hepatic malignancies

38. Lessons From Immune Checkpoint Inhibitor Trials in Hepatocellular Carcinoma

39. Shear Wave Elastography and Shear Wave Dispersion Imaging in the Assessment of Liver Disease in Alpha1-Antitrypsin Deficiency

40. Maternal Exercise Mediates Hepatic Metabolic Programming via Activation of AMPK-PGC1α Axis in the Offspring of Obese Mothers

43. From Liver Cirrhosis to Cancer: The Role of Micro-RNAs in Hepatocarcinogenesis

44. Elevated soluble urokinase plasminogen activator receptor serum levels indicate poor survival following transarterial chemoembolization therapy for hepatic malignancies: An exploratory analysis

45. In Vivo Models for Cholangiocarcinoma—What Can We Learn for Human Disease?

46. Serum levels of miR-223 but not miR-21 are decreased in patients with neuroendocrine tumors

47. Circulating levels of microRNA193a-5p predict outcome in early stage hepatocellular carcinoma

48. Intestinal Virome Signature Associated With Severity of Nonalcoholic Fatty Liver Disease.

49. High protein intake is associated with histological disease activity in patients with NAFLD

50. Phenotyping non‐alcoholic fatty liver disease by the gut microbiota: ready for prime time?

Catalog

Books, media, physical & digital resources